Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods

Journal of Epidemiology and Community Health

Volumn 60, Issue 8, 2006, Pages 712-720

  Leung, Gabriel M ^a,b   Woo, Pauline P S ^b   McGhee, Sarah M ^b   Cheung, Annie N Y ^b   Fan, Susan ^c   Mang, Oscar ^d   Thach, Thuan Q ^b   Ngan, Hextan Y S ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Family Planning Association of Hong Kong   (Hong Kong)

^d QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AGE-RELATED DIFFERENCE; BAYESIAN ANALYSIS; CANCER; COHORT ANALYSIS; MAXIMUM LIKELIHOOD ANALYSIS; WOMENS HEALTH;

ADULT; AGED; ARTICLE; BAYES THEOREM; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GROWTH; HONG KONG; HUMAN; INCIDENCE; LOGLINEAR MODEL; PREGNANT WOMAN; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BAYES THEOREM; COHORT STUDIES; FEMALE; HONG KONG; HUMANS; INCIDENCE; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; MASS SCREENING; MIDDLE AGED; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

ASIA; CHINA; EURASIA; FAR EAST; HONG KONG;

EID: 33746334446     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2005.042275     Document Type: Article

References (41)

1. Department of Health. Annual report 2002/2003. Hong Kong: Government Printers, 2003.
2. Osmond C, Gardner MJ. Age, period and cohort models applied to cancer mortality rates. Star Med 1982;1:245-59.
3. Zheng T, Mayne ST, Holford TR, et al. The time trend and age-period-cohort effects on incidence of oesophageal cancer in Connecticut, 1935-89. Cancer Causes Control 1992;3:481-92.
4. Adami HO, Bergstrom R, Sparen P, et al. Increasing cancer risk in younger birth cohorts in Sweden. Lancet 1993;341:773-7.
5. Persson I, Bergstrom R, Sparen P, et al. Trends in breast cancer incidence in Sweden 1958-1988 by time period and birth cohort. Br J Cancer 1993;68:1247-53.
6. Leung GM, Thach TQ, Lam TH, et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer 2002;87:982-8.
7. Wang PD, Lin RS. Age-period-cohort analysis of cervical cancer mortality in Taiwan, 1974-1992. Acta Obstet Gynecol Scand 1997;76:697-702.
8. Sasieni P, Adams J. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ 1999;318:1244-5.
9. Hong Kong Cancer Registry. Cancer incidence and mortality in Hong Kong 1995-1996. Hong Kong: Hospital Authority, 1999.
10. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai, Japan: Tohoku University Press, 1960.
11. Tarone RE, Chu K. Implications or birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 1992;84:1402-10.
12. Clayton D, Schifflers E, Models for temporal variation in cancer rates I: ageperiod and age-cohort models. Stat Med 1987;6:449-67.
13. Clayton D, Schifflers E. Models for temporal variation in cancer rates II: age-period-cohort models. Stat Med 1987;6:469-81.
14. Holford TR. The estimation of age, period, and cohort effects for vital rates. Biometrics 1983;39:311-24.
15. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991;12:425-57.
16. Tarone RE, Chu K. Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 1996;143:85-91.
17. Shahpar C, Li G. Homicidal mortality in the United States, 1935-1994: age, period and cohort effects. Am J Epidemiol 1999;125:1213-22.
18. McCullagh P, Nelder J. Generalised linear models. 2nd ed. London: Chapman and Hall, 1983.
19. Knorr-Held L, Rainer E. Prognosis of lung cancer mortality in West Germany: a case study in Bayesian prediction. Biostat 2001;2:109-29.
20. The University of Hong Kong. Population health survey report. Hong Kong: Department of Health, Government of the Hong Kong Special Administrative Region, People's Republic of China, 2005.
21. Adab P, McGhee SM, Yanova J, et al. Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening. Med Care 2004;42:600-9.
22. Hong Kong Census and Statistics Department. Thematic household survey report no 12. Hong Kong: Government Printers, 2003.
23. Leung GM, Lam TH, Thach TQ, et al. Rates of cesarean births in Hong Kong: 1987-1999. Birth 2001;28:166-72.
24. Hong Kong Census and Statistics Department. Total live births by age of mother. In: Hong Kong annual digest of statistics 1972-2002. Hong Kong: Government Printers, 1973-2003.
25. Anttila A, Nieminen P. Cervical cancer screening programme in Finland, Eur J Cancer 2000;36:2209-14.
26. Snider J, Beauvais J, Levy I, et al. Trends in mammography and pap smear utilization in Canada. Chronic diseases in Canada 1996;17:108-17.
27. Breen N, Kessler L. Trends in cancer screening-United States, 1987 and 1992. MMWR Morb Mort Wkly Rep 1995;45:57-61.
28. Department of Health. Cervical screening programme, England: 1994-95 to 1996-97. London Department of Health (Statistical bulletins 1996/3, 1996/26, 1997/27).
29. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
30. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003;9:348-59.
31. The Family Planning Association of Hong Kong. Report on the survey family planning in Hong Kong: knowledge, attitude and practice in 1967, 1972, 1977, 1982, 1987, 1992, 1997 and 2002.
32. The Family Planning Association of Hong Kong. Youth sexuality study reports in 1981, 1986, 1991, 1996 and 2001.
33. Bekkers RLM, Massuger LFAG, Bulten J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 2004;14:95-105.
34. Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002;185:28-35.
35. Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer 2002;100:327-31.
36. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
37. Lynge E, Madsen M, Engholm G. Effect of organized screening on incidence and mortality of cervical cancer in Denmark. Cancer Res 1989;49:2157-60.
38. Nieminen P, Kallio M, Anttila A, et al. Organized versus spontaneous papsmear screening for cervical cancer, a case control study. Int J Cancer 1999;83:55-8.
39. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
40. Paloma VA, Moreno V, Bosch F, et al. International trends in incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75:536-45.
41. Paloma VA, Moreno V, Bosch F, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000;86:429-35.